These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 11640883

  • 1. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer.
    Ullerås E, Miller SJ, Adam GI, Kanduri C, Wilcock AC, Franklin GC.
    Exp Cell Res; 2001 Nov 01; 270(2):188-98. PubMed ID: 11640883
    [Abstract] [Full Text] [Related]

  • 2. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 15; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 4. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N, Seuter S, Schnur N, Jung M, Steinhilber D.
    Biol Chem; 2003 May 15; 384(5):777-85. PubMed ID: 12817474
    [Abstract] [Full Text] [Related]

  • 5. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 7. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U, Renkawitz R, Baniahmad A.
    Anticancer Res; 2000 Oct 01; 20(2A):1017-22. PubMed ID: 10810390
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM, Soeth E, Smith CL.
    Oncogene; 2003 Jul 31; 22(31):4807-18. PubMed ID: 12894222
    [Abstract] [Full Text] [Related]

  • 9. An Inr-containing sequence flanking the TATA box of the human c-sis (PDGF-B) proto-oncogene promoter functions in cis as a co-activator for its intronic enhancer.
    Franklin GC, Adam GI, Miller SJ, Moncrieff CL, Ullerås E, Ohlsson R.
    Oncogene; 1995 Nov 02; 11(9):1873-84. PubMed ID: 7478617
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines.
    Ou JN, Torrisani J, Unterberger A, Provençal N, Shikimi K, Karimi M, Ekström TJ, Szyf M.
    Biochem Pharmacol; 2007 May 01; 73(9):1297-307. PubMed ID: 17276411
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
    Young DA, Billingham O, Sampieri CL, Edwards DR, Clark IM.
    FEBS J; 2005 Apr 15; 272(8):1912-26. PubMed ID: 15819885
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter.
    List HJ, Smith CL, Rodriguez O, Danielsen M, Riegel AT.
    Exp Cell Res; 1999 Nov 01; 252(2):471-8. PubMed ID: 10527637
    [Abstract] [Full Text] [Related]

  • 14. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 15. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec 20; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 16. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Björkholm M, Henriksson M, Gruber A, Xu D.
    Exp Cell Res; 2002 Mar 10; 274(1):25-34. PubMed ID: 11855854
    [Abstract] [Full Text] [Related]

  • 17. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.
    Nakajima H, Kim YB, Terano H, Yoshida M, Horinouchi S.
    Exp Cell Res; 1998 May 25; 241(1):126-33. PubMed ID: 9633520
    [Abstract] [Full Text] [Related]

  • 18. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
    Liu BH, Wang X, Ma YX, Wang S.
    Gene Ther; 2004 Jan 25; 11(1):52-60. PubMed ID: 14681697
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T.
    Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822
    [Abstract] [Full Text] [Related]

  • 20. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
    Han S, Lu J, Zhang Y, Cheng C, Li L, Han L, Huang B.
    Immunol Lett; 2007 Feb 15; 108(2):143-50. PubMed ID: 17270283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.